florfenicol has been researched along with maduramicin in 1 studies
| Studies (florfenicol) | Trials (florfenicol) | Recent Studies (post-2010) (florfenicol) | Studies (maduramicin) | Trials (maduramicin) | Recent Studies (post-2010) (maduramicin) |
|---|---|---|---|---|---|
| 628 | 70 | 420 | 83 | 2 | 33 |
| Protein | Taxonomy | florfenicol (IC50) | maduramicin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.034 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.18 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.702 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.027 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.61 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0078 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.908 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.128 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0087 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.034 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0078 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.027 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.033 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.0017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Guo, YG; Jiang, SX; Tu, P; Wang, GY | 1 |
1 other study(ies) available for florfenicol and maduramicin
| Article | Year |
|---|---|
Effect of three polyether ionophores on pharmacokinetics of florfenicol in male broilers.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chickens; Chromatography, High Pressure Liquid; Coccidiostats; Drug Interactions; Drug Therapy, Combination; Injections, Intravenous; Ionophores; Lactones; Male; Monensin; Pyrans; Thiamphenicol | 2013 |